BENVENUTI, MANUELA
 Distribuzione geografica
Continente #
EU - Europa 2.758
NA - Nord America 2.617
AS - Asia 462
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
AF - Africa 1
Totale 5.853
Nazione #
US - Stati Uniti d'America 2.611
GB - Regno Unito 789
IE - Irlanda 555
CN - Cina 392
IT - Italia 342
UA - Ucraina 294
SE - Svezia 256
DE - Germania 170
FR - Francia 135
FI - Finlandia 96
RU - Federazione Russa 37
SG - Singapore 21
VN - Vietnam 21
CZ - Repubblica Ceca 20
BE - Belgio 14
NL - Olanda 12
PL - Polonia 11
IN - India 10
AU - Australia 7
AT - Austria 4
CA - Canada 4
EU - Europa 4
CH - Svizzera 3
GR - Grecia 3
JP - Giappone 3
LU - Lussemburgo 3
ES - Italia 2
HK - Hong Kong 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KR - Corea 2
MK - Macedonia 2
PH - Filippine 2
PT - Portogallo 2
AL - Albania 1
BG - Bulgaria 1
BO - Bolivia 1
BR - Brasile 1
CL - Cile 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ID - Indonesia 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
Totale 5.853
Città #
Southend 712
Dublin 555
Chandler 305
Fairfield 305
Jacksonville 241
Ashburn 167
Woodbridge 167
Wilmington 137
Cambridge 112
Seattle 112
Houston 111
Princeton 109
Ann Arbor 101
Siena 94
Menlo Park 87
Nanjing 87
Beijing 75
Boardman 56
Fremont 55
Helsinki 46
San Mateo 37
New York 35
San Diego 35
Sesto Fiorentino 33
Moscow 28
Nanchang 28
Shanghai 24
Dong Ket 21
London 17
Shenyang 17
Venezia 17
Changsha 15
Florence 15
Lancaster 15
Brussels 14
Jiaxing 14
Kunming 14
Tianjin 14
Brno 13
Milan 13
Jinan 11
Singapore 11
Amsterdam 10
Norwalk 10
Düsseldorf 9
Hangzhou 9
San Francisco 9
Zhengzhou 9
Hebei 8
Rome 8
West Jordan 8
Dearborn 7
Munich 7
Ningbo 7
Olomouc 7
Gdynia 6
Chicago 5
Guangzhou 5
Taizhou 5
Auburn Hills 4
Bari 4
Haikou 4
Paris 4
Philadelphia 4
Pisa 4
Pontedera 4
Redwood City 4
Vienna 4
Canberra 3
Changchun 3
Edinburgh 3
Empoli 3
Frankfurt am Main 3
Hanover 3
Hefei 3
Kilburn 3
Luxembourg 3
Nuremberg 3
Prato 3
Roorkee 3
Shijiazhuang 3
Tappahannock 3
Torino 3
Wroclaw 3
Acton 2
Almada 2
Athens 2
Atlanta 2
Bitonto 2
Bologna 2
Budapest 2
Campi Bisenzio 2
Caselle Torinese 2
Columbus 2
Corbetta 2
Dobong-gu 2
Fort Worth 2
Indore 2
Irvine 2
Islington 2
Totale 4.320
Nome #
VNRX-5133 (Taniborbactam), a broad-spectrum inhibitor of serine- And metallo-β-lactamases, restores activity of cefepime in enterobacterales and Pseudomonas aeruginosa 168
SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model 154
X-ray Crystal Structure of the Acinetobacter baumannii OXA-24/40 Class D Carbapenemase Inhibited by NXL104 139
Crystal structure of the Pseudomonas aeruginosa BEL-1 extended-spectrum β-lactamase and its complexes with moxalactam and imipenem 136
Atomic-Resolution Structure of a Class C β-Lactamase and Its Complex with Avibactam 134
Amino-thiadiazole as innovative inhibitors of human glutaminyl cyclase, a validated target towards Alzheimer disease 132
Crystal structure of AphA class B acid phosphatase/phosphotransferase from E. coli 130
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- And Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections 130
Crystal structure of the extended-spectrum β-lactamase BEL-1, in native form and in complex with imipenem and moxalactam. 128
A structure-based proposal for the catalytic mechanism of the bacterial acid phosphatase AphA belonging to the DDDD superfamily of phosphohydrolases 127
The structure of the human glutaminyl cyclase–SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders 127
Boric acid and acetate anion binding to subclass B3 metallo-β-lactamase BJP-1 provides clues for mechanism of action and inhibitor design 121
null 120
Crystallization and preliminary crystallographic analysis of the hydroxyquinol 1,2-dioxygenase from Nocardioides simplex 3E: a novel dioxygenase involved in the biodegradation of polychlorinated aromatic compounds 120
Crystallization of soluble proteins in vapor diffusion for x-ray crystallography 119
Structural characterisation of a new heparinisable material based on ethylene/vinyl alcohol/vinyl acetate terpolymer and a poly(amido-amine) 119
XAS of dilute biological samples 117
Sulfated hyaluronic acid as heparin-like material: physicochemical and biological characterization 117
Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC  beta-Lactamases 111
The evolutionarily conserved trimeric structure of CutA1 proteins suggests a role in signal transduction 109
The soluble Y115E-Y117E variant of human glutaminyl cyclase is a valid target for X-ray and NMR screening of inhibitors against Alzheimer disease 109
Characterization of the metallocenter of rabbit skeletal muscle AMP deaminase. Evidence for a dinuclear zinc site 109
Sulfated hyaluronic acid as heparin-like material: physico-chemical and biological characterization 108
From an inactive prokaryotic SOD homologue to an active protein through site-directed mutagenesis 108
Evolution to carbapenem -hydrolyzing activity in noncarbapenemase class D beta-lactamase OXA-10 by rational protein design 107
Sulfated hyaluronic acid as heparin-like material: physico-chemical and biological characterization 105
The first structure of a bacterial class B acid phosphatase reveals further structural heterogeneity among phosphatases of the haloacid dehalogenase fold 105
Structural Insights into the Catalytic Mechanism of the Bacterial Class B Phosphatase AphA Belonging to the DDDD Superfamily of Phosphohydrolases 104
Crystal structure of the narrow-spectrum OXA-46 class D beta-lactamase: relationship between active-site lysine carbamylation and inhibition by polycarboxylates 104
High-Resolution Crystal Structure of the Subclass B3 Metallo-beta-Lactamase BJP-1: Rational Basis for Substrate Specificity and Interaction with Sulfonamides 104
Crystal structure and mutational analysis of FUS-1 (OXA-85), a class D beta-lactamase from Fusobacterium nucleatum subsp. polymorphum 102
Crystal structure of the OXA-48 beta-lactamase reveals mechanistic diversity among class D carbapenemases 101
1,2,4-Triazole-3-Thione analogues with a 2-Ethylbenzoic acid at position 4 as VIM-type metallo-β-Lactamase inhibitors 100
ANT2681: SAR studies leading to the identification of a metallo-β-lactamase inhibitor with potential for clinical use in combination with meropenem for the treatment of infections caused by NDM-Producing enterobacteriaceae 100
1,2,4-Triazole-3-thione compounds with a 4-ethyl alkyl/aryl sulfide substituent are broad-spectrum metallo-β-lactamase inhibitors with re-sensitization activity 98
4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors 97
Structure of the extended-spectrum beta-lactamase TEM-72 inhibited by citrate 89
Preparation, physico-chemical and biological characterization of heparinizable materials 89
Discovery of ANT3310, a novel broad-spectrum serine β-Lactamase inhibitor of the diazabicyclooctane class, which strongly potentiates meropenem activity against carbapenem-resistant enterobacterales and acinetobacter baumannii 89
Structural and functional characterization of two new class D beta-lactamases: OXA-46 and OXA-48 85
Crystal structure of Enterococcus faecalis Thymidylate synthase 85
New trends in blood compatible materials 84
Acid-base properties and complexing abilities of an aminodicarboxylic acid and its corresponding polymer 84
Metallo-enzyme mechanism from accurate structural data 83
Evolution to carbapenem-hydrolyzing activity in class D β-lactamases by rational protein design. 80
Derivati solfatati dell'acido ialuronico come prodotto eparino-simili: caratterizzazione chimico-fisica e biologica 78
Adsorption of metal ions from sulphuric acid solution by chelating resins 71
Crystallographic studies of new human Thymidylate synthase inhibitors 69
Materials containing heparin complexing polymers, physicochemical characterization and compatibility 68
Expression, purification, crystallization and preliminary X-ray characterization of the class B acid phosphatase (AphA) from Escherichia coli 67
Crystallographic studies of new human Thymidylate synthase inhibitors 65
Crystallographic studies of new human Thymidylate synthase inhibitors. 64
Derivati solfatati dell'acido ialuronico come prodotti eparino-simili: caratterizzazione chimico-fisica e biologica 62
Synthesis of two novel heparinizable polymeric materials (EVAPA-45 and EVAPA) for hemodialysis membranes 55
Synthesis of two novel heparinizable polymeric materials starting from an ethylene/vinyl alcohol/vinyl acetate terpolymer 55
Calorimetric study of macromolecular complex formation between heparin and poly(amido-amine)s. 55
null 54
New macromolecular ligands. Basicity and complexing properties of monomeric and polymeric dicarboxylic aminoacids 47
Synthesis and chemical characterization: characterization of biomaterials in contact with blood 45
Large size chelate rings in copper(II) complexes with triamine 42
Structural and functional characterization of two new class D beta-lactamase: OXA-46 and OXA-48 42
Optimization of 1,2,4-Triazole-3-thiones toward Broad-Spectrum Metallo-β-lactamase Inhibitors Showing Potent Synergistic Activity on VIM- and NDM-1-Producing Clinical Isolates 22
Totale 5.948
Categoria #
all - tutte 18.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.043 166 35 73 151 62 56 79 138 94 92 24 73
2020/2021973 32 98 22 72 76 141 38 157 120 77 56 84
2021/2022771 38 99 69 49 79 27 34 39 27 78 62 170
2022/20231.080 70 77 128 136 116 238 17 104 131 12 27 24
2023/2024904 43 16 60 34 53 206 292 24 2 30 29 115
2024/202561 61 0 0 0 0 0 0 0 0 0 0 0
Totale 5.948